Dermira Inc buy melinda
Start price
06.12.17
/
50%
€21.95
Target price
29.12.17
€26.61
Performance (%)
14.95%
End price
29.12.17
€25.24
Summary
This prediction ended on 29.12.17 with a price of €25.24. The BUY prediction by melinda finished with a performance of 14.95%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Dermira Inc | - | - | - | - |
| iShares Core DAX® | 0.224% | 1.487% | 3.575% | 50.284% |
| iShares Nasdaq 100 | 6.047% | 16.188% | 39.144% | 107.459% |
| iShares Nikkei 225® | 5.724% | 11.690% | 50.962% | 76.350% |
| iShares S&P 500 | 2.172% | 8.056% | 25.618% | 72.625% |
Comments by melinda for this prediction
In the thread Dermira Inc diskutieren
Olasacostat glasarétil (DRM01) Akne
Abgeschlossene Phase - 3 - Zulassungs kündigte am 5. Oktober 2017. Die Daten werden im ersten Quartal 2018 erhalten.
(Vom Mitglied beendet)